Angiotensin‐converting enzyme inhibitors vs placebo
All‐cause mortality · people with sickle cell disease
The review found no eligible studies for this question.
1 finding from 1 review
- Interventions for chronic kidney disease in people with sickle cell disease 2023 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found